In 2N patients, we saw aberrations, e.g., in Chr.16p13.11, that harbor at least four genes (ABCC1, FOPNL, MYH11, KIAA0430) involved in cancer development or that are present in rare CNVs in cancer patients. This evidence concerns the gene MYH11 and cancer.